Medtronic Plc (MDT)
94.17
+1.07
(+1.15%)
USD |
NYSE |
Sep 04, 16:00
94.25
+0.08
(+0.08%)
After-Hours: 20:00
Medtronic Research and Development Expense (Quarterly) : 771.00M for July 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2026 | 771.00M |
| April 30, 2026 | 671.00M |
| January 31, 2026 | 722.00M |
| October 31, 2025 | 754.00M |
| July 31, 2025 | 726.00M |
| April 30, 2025 | 684.00M |
| January 31, 2025 | 675.00M |
| October 31, 2024 | 697.00M |
| July 31, 2024 | 676.00M |
| April 30, 2024 | 675.00M |
| January 31, 2024 | 695.00M |
| October 31, 2023 | 698.00M |
| July 31, 2023 | 668.00M |
| April 30, 2023 | 639.00M |
| January 31, 2023 | 688.00M |
| October 31, 2022 | 676.00M |
| July 31, 2022 | 692.00M |
| April 30, 2022 | 652.00M |
| January 31, 2022 | 657.00M |
| October 31, 2021 | 676.00M |
| July 31, 2021 | 750.00M |
| April 30, 2021 | 632.00M |
| January 31, 2021 | 601.00M |
| October 31, 2020 | 639.00M |
| July 31, 2020 | 621.00M |
| Date | Value |
|---|---|
| April 30, 2020 | 567.00M |
| January 31, 2020 | 573.00M |
| October 31, 2019 | 603.00M |
| July 31, 2019 | 587.00M |
| April 30, 2019 | 594.00M |
| January 31, 2019 | 561.00M |
| October 31, 2018 | 590.00M |
| July 31, 2018 | 585.00M |
| April 30, 2018 | 592.00M |
| January 31, 2018 | 559.00M |
| October 31, 2017 | 556.00M |
| July 31, 2017 | 548.00M |
| April 30, 2017 | 553.00M |
| January 31, 2017 | 530.00M |
| October 31, 2016 | 554.00M |
| July 31, 2016 | 556.00M |
| April 30, 2016 | 575.00M |
| January 31, 2016 | 546.00M |
| October 31, 2015 | 545.00M |
| July 31, 2015 | 558.00M |
| April 30, 2015 | 528.00M |
| January 31, 2015 | 373.00M |
| October 31, 2014 | 374.00M |
| July 31, 2014 | 365.00M |
| April 30, 2014 | 385.00M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| STERIS Plc (Ireland) | 28.60M |
| Abbott Laboratories | 892.00M |
| Becton, Dickinson & Co. | 258.00M |
| Boston Scientific Corp. | 554.00M |
| Intuitive Surgical, Inc. | 370.40M |